首頁 > 市場調查報告書 > 醫療設備

導管

市場調查報告書

商品編碼

2150670

植入式靜脈通路端口市場報告：趨勢、預測和競爭分析（至2035年）

Implantable Venous Access Port Market Report: Trends, Forecast and Competitive Analysis to 2035

出版日期: 2026年10月15日 | 出版商:

Lucintel | 英文 150 Pages | 商品交期: 3個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄圖表

植入式靜脈通路端口市場

受靜脈化療和營養支持療法市場機會的推動，全球植入式靜脈輸液港市場前景看好。預計到2035年，全球植入式靜脈輸液港市場規模將從2027年的6.098億美元成長至9.218億美元，2027年至2035年的年複合成長率（CAGR）為2.7%。推動市場成長的主要因素包括慢性病盛行率的上升、對長期靜脈通路需求的成長以及微創手術的日益普及。

根據 Lucintel 的預測，由於鈦金屬輸液港具有優異的生物相容性和耐用性，預計在預測期內將實現高速成長。
從應用角度來看，需要反覆進行靜脈化療的癌症患者人數不斷增加，預計將在預測期內推動靜脈化療行業的更高成長。
從區域來看，亞太地區（APAC）預計將在預測期內呈現最高的成長率，這主要得益於癌症患者數量的增加和腫瘤相關醫療設施的擴張。

植入式靜脈通路端口市場的新趨勢

2025年至2027年間，靜脈注射治療（IVAP）市場預計將從以流程為中心的模式轉向以價值為中心的模式。許多醫院正在啟動或擴大門診癌症治療項目，並專注於使用能夠最大限度降低醫療相關感染風險的醫療設備。在醫院提供的所有癌症相關服務中，癌症治療服務預計將在整個預測期內保持主導地位。 Lucintel預測，除了實證醫學和服務之外，生產製造也將在競爭中發揮重要作用。

感染預防：抗菌和/或無針導管系統的使用呈現強勁的市場趨勢。儘管醫療相關感染是可以預防的，但導管相關血流感染（CRBSI）在許多醫院仍然時有發生。醫療機構正轉向採購有助於預防CRBSI的產品。預計在未來3至5年內，選擇用於預防感染的輸液港將成為標準做法。
門診癌症治療：藥理學的進步使得許多癌症和血液疾病的治療可以在門診進行。靜脈輸液港（IVAP）的使用可以實現長期輸液，從而提高患者在治療期間的舒適度。
醫療設備標準化：製造商正根據醫院的回饋意見，將醫療設備的組件標準化。這些回饋意見旨在減少特定器械的變體數量，並簡化相關培訓。醫療設備標準化的一個方面是提高器械的連接埠速度。此標準針對的是運轉速度高達 5 mL/s 的器械。該標準計劃於 2025 年進行修訂，在此之前，採購器械時，符合該標準將優先於價格因素。
供應穩定性：採購機構將為特定醫療設備尋找多家供應商。在新冠疫情期間，人們清楚地意識到，依賴單一供應商供應醫療設備會增加供應鏈風險。儘管在此期間供應商的價格和成本有所上漲，但採購機構將根據醫療設備的供應情況以及供應商取得額外供應的意願，認證更多供應商。
定價與高階連接埠：圍繞高階連接埠的競爭焦點正從行銷轉向連接埠和存取設備的研發，這些設備可用於整合臨床數據，從而最佳化醫療手術流程。長期易用性正成為連接埠和存取設備的關鍵差異化因素。短期內，醫院願意為那些整合易用性功能、能夠改善工作流程並減少特定手術所需介入次數的設備支付溢價。

由於癌症的影響以及長期治療的複雜性，對醫療設備的需求預計將會增加。器械採購將基於成本和對醫療機構的整體影響。預計人們將更加關注臨床結果。可靠的本地醫療設備供應商可望擴大市場佔有率。

植入式靜脈通路裝置（IVAP）市場的最新趨勢

2025年至2027年，由於癌症診斷率上升、治療週期延長以及醫院擴大採用永久性血管通路，預計靜脈內血管通路（IVAP）市場將保持穩定成長。 Lucintel預測市場將持續成長，但重點應放在市場價值而非銷售量。安全性、植入便利性和產品多樣性將繼續推動市場競爭。

擴大產能：一家總部位於歐洲的製造商於2025年2月宣布，將將用於腫瘤治療的無菌醫療設備的產能提高20%。預計這將有助於滿足該公司醫療設備日益成長的需求。
收購趨勢：2025年5月，另一家製造商宣布將以1.5億美元收購導管植入設備公司。預計大型公司將透過收購小型公司來增強業務多元化和競爭力。
新技術引進：2025年6月，另一家製造商推出了一款流速為每秒5毫升的醫用輸液港。採用這項技術的輸液港可望減少醫療設備的維護頻率。
策略合作：2025年9月，一家輸液港製造商與一個擁有30多家醫療機構的醫院網路合作，開始追蹤導管的效能。醫院採購委員會越來越傾向於根據治療總成本（包括感染風險和平均導管留置時間）來評估產品。
政府批准：2026年1月，監管機構批准了一種植入期為10年的輸液港系統。植入期較長的輸液港系統可能會導致需要反覆輸液治療的患者使用量增加。

未來五年，能夠提供安全、有效、高效且併發症發生率低的血管通路導管系統預計將在市場上站穩腳跟。抗癌藥物市場預計仍將是靜脈導管的最大市場，但其他市場，特別是門診靜脈治療和長期重複靜脈治療領域，預計也將成長。基於真實世界數據的證據將是簽訂長期合約的關鍵因素。

歐洲植入式靜脈通路端口市場：按類型分類
歐洲植入式靜脈通路端口市場：按應用領域分類
德國植入式靜脈通路端口市場
法國植入式靜脈通路端口市場
義大利植入式靜脈通路端口市場
西班牙植入式靜脈通路端口市場
英國植入式靜脈通路端口市場

第9章：亞太地區植入式靜脈通路裝置市場

亞太地區植入式靜脈通路港市場：依類型分類
亞太地區植入式靜脈通路端口市場：按應用分類
中國植入式靜脈通路端口市場
印度植入式靜脈通路端口市場
日本植入式靜脈通路端口市場
韓國植入式靜脈通路端口市場
印尼植入式靜脈通路端口市場

第10章：世界戰爭（Royal-of-War）系統中植入式靜脈通路端口的市場

植入式靜脈通路端口的其他區域市場：按類型分類
其他地區植入式靜脈通路端口市場：按應用領域分類
中東市場對植入式靜脈通路裝置的需求
南美洲市場對植入式靜脈通路裝置的需求
非洲植入式靜脈通路端口市場

第11章競爭分析

產品系列分析
業務整合
波特五力分析
市佔率分析

第12章機會與策略分析

價值鏈分析
成長機會分析
新趨勢：全球植入式靜脈通路市場
戰略分析

第13章：價值鏈中關鍵企業的公司概況

競爭分析概述
BD
AngioDynamics
ICU Medical
B. Braun Medical
PFM Medical
Vygon
Districlass
PakuMed
Linhua Medical
Fresenius

第14章附錄

簡介目錄圖表

Implantable Venous Access Port Market

The future of the global implantable venous access port market looks promising with opportunities in the intravenous chemotherapy and nutritional support treatment markets. The global implantable venous access port market is expected to reach an estimated $921.8 million by 2035 from $609.8 million in 2027 with a CAGR of 2.7% from 2027 to 2035. The major drivers for this market are the increasing prevalence of chronic diseases, the rising demand for long-term intravenous access, and the growing adoption of minimally invasive procedures.

Lucintel forecasts that, within the type category, titanium infusion port is expected to witness higher growth over the forecast period due to better biocompatibility and durability of infusion ports made of titanium.
Within the application category, intravenous chemotherapy is expected to witness higher growth over the forecast period due to increasing prevalence of cancers requiring repeated IV chemotherapy.
In terms of regions, APAC is expected to witness the highest growth over the forecast period due to increasing population of cancer patients and the expanding oncology service facilities.

Emerging Trends in Implantable Venous Access Port Market

Between 2025 and 2027, the IVAP market will evolve from a procedure-focused to a value-focused model. Most hospitals have initiated or expanded outpatient cancer treatment programs and have focused on the use of devices that minimize the risk of health care associated infections. Of all the oncology-related services offered by hospitals, the oncology service line is expected to maintain its dominant position during the forecast period. Lucintel anticipates that in addition to evidence and service, manufacturing also will play an important role in competition.

Infection Prevention: There is a strong market trend towards the use of antimicrobial and/or needleless catheter systems. Even though health care associated infections are preventable, many hospitals still experience catheter-related blood stream infections (CRBSIs). Providers are shifting to the purchase of products that will aid in the prevention of CRBSIs. It is expected that infection prevention port selection will be the norm within the next three to five years.
Outpatient Oncology: Due to advances in pharmacology, more and more oncology and hematology related therapies will be administered on an outpatient basis. The use of IVAPs will provide access over a long period of time and will allow the patient to be comfortable during treatment.
Standardizing Devices: Manufacturers are standardizing elements of their medical devices based on feedback from hospitals. This feedback has focused on reducing the number of variations of a particular device and simplifying the training needed for a given device. One facet of medical device standardization has been advancing the port speed of devices. The focus of the standard has been on devices rated to operate at speeds of up to 5 mL/s. The standard will be reviewed by 2025, and in the interim, the focus of device procurement will be based on the compliance of the device with the standard rather than price.
Resilient Supplies: Purchasing organizations will seek multiple suppliers for a given device. The purchasing organization's reliance on a single supplier for a device was demonstrated during the COVID-19 pandemic to increase supply chain risk. While supplier price and cost will increase during this period, the purchasing organizations will qualify a larger number of suppliers based on the availability of the device and the organizations' willingness to carry additional supply.
Pricing and Premium Ports: The competition for premium ports has shifted focus from marketing to the design and development of ports and access devices for medical procedures that integrate clinical data. Long-term usability has become a differentiator for ports and access devices. In the short term, hospitals will be willing to pay a premium for devices that integrate usability features that improve workflow and reduce the number of interventions needed for a given procedure.

Due to the impact of cancer and the lengthy and complex treatment, the demand for medical devices is expected to increase. Devices will be purchased based on the cost and the overall impact on the medical facility. A greater focus on clinical outcomes is expected. Dependable, regional medical device suppliers are expected to increase market share.

Recent Developments in the Implantable Venous Access Port Market

Stable Growth is expected to occur in the IVAP market between the years 2025-2027 due to more cancer patients being diagnosed, longer treatment durations, and the preference by hospitals to use more permanent vascular accesses. Lucintel expects that the market will continue to grow, however, the main focus should be more on the value of the market as opposed to the volume. Safety, ease of placement, and product variety will continue to drive market competition.

Capacity Expansion: A manufacturer based in Europe announced in February 2025 that they would be increasing their production capacity of sterile devices used for oncology access by 20%. This was expected to help meet the growing demand for their devices.
Acquisition Activity: In May 2025, a different manufacturer announced the acquisition of a catheter-placement device company for 150 million dollars. It is expected that larger companies will acquire smaller companies in order to gain more business variety and strength.
Technology Launch: In June 2025, a different manufacturer released a medical port that has a flow rate of 5 ml per second. It is expected that ports with this technology will help reduce the number of medical device workshops that are performed.
Strategic Collaboration: A port manufacturer and a hospital network with 30+ locations partnered in September 2025 to track the performance of catheters. Hospital purchasing committees are increasingly evaluating products based on the total cost to administer the therapy (including the infection risk and the average dwelling time of the catheter).
Government Approval: In January 2026, a regulatory agency granted a port system with 10-years' implantable claim. Longer duration port systems may lead to expanded use by patients requiring repeated infusion therapies.

It is expected that in the coming five years, the market will comprehend catheter systems that enable the integration of safe, effective and efficient vascular access with lower complication rates. The oncology market will continue to be the largest market for infusion catheters; however, other markets, especially outpatient infusion and long term/repetitive infusion therapies will also experience growth. Evidence based on real world data will be the determining factor in long term contracts.

Strategic Growth Opportunities in the Implantable Venous Access Port Market

Between 2024 and 2026, various trends in the cancer industry will create opportunities for the implantable venous access port market. These include increasing rates of cancer, hospitals and healthcare systems transitioning to outpatient infusion and/or primary cancer treatment, and healthcare systems evaluating the total cost of cancer treatment. Based upon information from Lucintel, the market will also benefit from the increasing demand for safety and quality, expansion of port indications, and the adoption of a service-based model. Clinical and economic integration will play a role in the differentiation of medical device port suppliers.

Paediatric and Neonatal Applications: A safer, lower-profile medical port for frequent chemotherapy or nutritional infusion would help children and teens as well as younger cancer patients. According to the American Cancer Society, approximately 9,550 children will be diagnosed with cancer in 2025.
Home Infusion Expansion: The market for medical ports would also benefit from the increasing trend of patients receiving infusion therapies in the home. In March 2025, the National Home Infusion Association reported that there were more than 3,000 provider agencies in the U.S. and territories.
Premium Products: Antimicrobial-coated and other infection-reducing products, such as catheters, will be more expensive due to hospital reimbursement cuts associated with reductions in bloodstream infections and readmission rates. In April 2025, the CDC reported on central line associated bloodstream infections and encouraged the purchase of high-risk, high-return products for the prevention of such infections.
Ambulatory Oncology Centres: The growing demand for cancer treatment and the shift of oncology care to the outpatient setting increases the need for faster and easier methods of vascular access. The U.S. is projected to have more than 2 million new cases of cancer in 2025.
Training and Distribution in High-Growth Markets: Further development of more affordable access devices and their incorporation into outpatient care in more high-growth market countries, where access is currently restricted to tertiary care centres, is expected. In 2025, the World Bank reported that markets with a higher-middle income status represented more than 75% of the world's population.

During the next five years, there will be significant new opportunities for companies to enter the global market with safe and affordable access products for the delivery of cancer treatment and other care requiring the use of access port products.

Implantable Venous Access Port Market Drivers and Challenges

The market for implantable venous access ports is set to benefit from various factors including advancements in medical technology, increase in the number of people with chronic conditions, growing investments in healthcare, and alterations in regulatory frameworks. There is growing need for reliable, long-term, venous access in the field of oncology and auscultatory care.

The factors responsible for driving this market include:

Patient Demand: Long term effects of cancers and other chronic conditions, prolonged treatment and more oncological and infusion therapies provided outside of a hospital, have increased the need for long term intravenous access. Implantable venous access ports aid in the insertion of IV lines for administration of chemotherapeutic and other infusion therapies as well as blood transfusions and sampling. According to the World Health Organization, in 2022, more than 20 million cases of cancer were reported and each year the global burden of cancer is expected to increase.
Technology Improvement: Improvements in materials science has improved the design of port chambers, catheters and other components of infusion devices. Further, advances have been made in needle-resistant and radio-opaque infusion devices. As a result, device manufacturers are able to design devices that are not only safer but more easily used by clinical staff. Also, device manufacturers have developed port systems that are more anatomically appropriate for children and other fragile patients. Innovations in implantation systems and techniques have reduced the risk of complications. Many of these innovations are focused on improving the durability of implantable infusion devices. These innovations have increased the demand for infusion devices and have enabled the use of premium infusion devices.
Revision of Regulations and Clinical Guidelines: A greater emphasis on regulations for the post-market surveillance of infusion devices, combined with the increased availability of clinical guidelines, have improved the confidence of the healthcare community in implantable infusion devices. This has reduced the number of needless complications. During this period, many healthcare facilities transitioned to using evidence-based devices and abandoned devices for which there was no evidence to support their use. The same trend was observed in other regulated industries.
Outpatient Care Infrastructure: Outpatient cancer care, home-based infusion services, and other ambulatory services have expanded. Like inpatient services, outpatient infusion services have a growing need for long-term vascular access. A port allows outpatient infusion services and decreases length of stay on inpatient services. The U.S. has over 6000 certified ambulatory surgery centres. Ports allow patients to receive repeated infusion services and reduce overall costs. Decentralized services increase the need for products that are designed to be maintained by the consumer. The next three to five years will increase the need for portable vascular access devices.
Supply and Demand: Increased competition and improvement in the manufacturing and supply of medical devices leads to a greater variety of products. Some of these improvements include the incorporation of antimicrobial covers, and other design features that allow power injection and portability. In June 2025, there was a continued trend of health care institutions and suppliers implementing a strategy of dual supplier for Medical Devices. Improvement in manufacturing will allow better pricing and increased availability of these medical devices.

The challenges facing this market include:

Catheter-related Infections and Related Complications: Bloodstream infections remain a concern. Other complications include clots and blockages. While new methods to insert and maintain central catheter lines have lowered complication rates, complications may still occur and require hospitalization and/or port removal. The Centers for Disease Control and Prevention recommends the use of standard techniques for central line insertions, and access-site assessments. Antimicrobial ports and other devices that incorporate additional features to prevent infection, along with staff training, will likely be purchased in the next three to five years.
Costs Associated with Procedures and The Total Cost of Care: Central catheter lines require several procedures and increase the cost of care. In lower-income countries, the high cost may limit the use of central catheter lines. Even in higher-income countries, costs may not be fully covered. In the next three to five years, ports that reduce the overall cost of care by reducing the total number of procedures needed and complications that require treatment to be postponed or interrupted will likely be utilized.
Supply Chain and Regulatory Complexity: Supply disruptions and the longest delays in the medical device supply chain are attributed to specialized polymers and metals, surface coatings, and final product sterilization. Other complexities include global regulatory variations and strict quality requirements. In September 2025, many device manufacturers continued to stockpile device inventories, largely due to persisting international supply chain disruptions and variability in Logistics. It is anticipated that during the next 3 to 5 years, device manufacturers with regionally diverse supplier networks, and production and digital traceability, and advanced regulatory and Health Authority approvals and engagements, will be best positioned to keep device inventories continuously available.

Improving technology, health care infrastructure investments and other factors will allow health care providers to deliver safe and more effective access to care outside of traditional health care facilities. While many barriers will be overcome to provide safer and better access to care, other barriers, including infection risk, cost, reimbursement, and supply and regulation, will continue to constrain the access port device market. Factors that will differentiate access device market competitors will be production and distribution.

List of Implantable Venous Access Port Market Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. Through these strategies implantable venous access port market companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the implantable venous access port market companies profiled in this report include-

BD
AngioDynamics
ICU Medical
B. Braun Medical
PFM Medical
Vygon
Districlass
PakuMed
Linhua Medical
Fresenius

Implantable Venous Access Port Market by Segment

The study includes a forecast for the global implantable venous access port market by type, application, and region.

Implantable Venous Access Port Market by Type [Value ($M) from 2019 to 2035]:

Titanium Infusion Port
Plastic Infusion Port

Implantable Venous Access Port Market by Application [Value ($M) from 2019 to 2035]:

Intravenous Chemotherapy
Nutritional Support Treatment

Implantable Venous Access Port Market by Region [Value ($M) from 2019 to 2035]:

North America
Europe
Asia Pacific
The Rest of the World

Country Wise Outlook for the Implantable Venous Access Port Market

The implantable venous access port market is being affected by different trends including the need for Long Term venous access devices for cancer treatment. Other trends include tighter regulations by governments, and on-site manufacturing of medical devices. There are ongoing efforts to improve the safety and reliability of power injection devices, and address challenges in the device supply chain. Lucintel expects these efforts will help companies enhance their competitive positions in the market.

United States: Recently, the focus has been on improving medical ports to allow power injection of 5mL. Examples include products in the BD PowerPort product line. These port developments are essential, especially with the rising trend of performing oncology treatments at outpatient and cancer infusion centres.
China: Similar to the United States, the focus in China has been on strengthening local manufacturing of infusion ports and catheters. In 2025, MicroPort reported having over 20,000 employees, and in the next 3-5 years it is expected that they and other Chinese device companies will improve the local supply of infusion ports to compete with imported infusion ports.
Germany: Though Celsite ports systems remain aligned to EU MDR requirements, process to update other product lines is ongoing. From May 2024, most legacy devices would require compliance with MDR. This highlights importance of traceable manufacturing and certification for implantable devices.
India: The FY2025 disclosures of Poly Medicure Ltd. indicate capital expenditures for expansion of manufacturing capabilities and further investments in its product portfolio, which already includes implantable access products (March 2025). Increasing local manufacture of vascular access products is expected to improve the safety and quality of India's health-care services.
Japan: With consolidated net sales of approximately 1 trillion yen in fiscal 2025 (March 2026), Terumo Corporation continued to strengthen its interventional and other hospital products while keeping its vascular access devices manufacturing and supplying business. Reliable and safe vascular access products are of high importance for the Japanese population, which is significantly aging and in which cancer prevalence is high.

Features of the Global Implantable Venous Access Port Market

Market Size Estimates: implantable venous access port market size estimation in terms of value ($B).
Trend and Forecast Analysis: Market trends (2019 to 2026) and forecast (2027 to 2035) by various segments and regions.
Segmentation Analysis: implantable venous access port market size by type, application, and region in terms of value ($B).
Regional Analysis: implantable venous access port market breakdown by North America, Europe, Asia Pacific, and Rest of the World.
Growth Opportunities: Analysis of growth opportunities in different types, applications, and regions for the implantable venous access port market.
Strategic Analysis: This includes M&A, new product development, and competitive landscape of the implantable venous access port market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

If you are looking to expand your business in this or adjacent markets, then contact us. We have done hundreds of strategic consulting projects in market entry, opportunity screening, due diligence, supply chain analysis, M & A, and more.

This report answers following 11 key questions:

Q.1. What are some of the most promising, high-growth opportunities for the implantable venous access port market by type (titanium infusion port and plastic infusion port), application (intravenous chemotherapy and nutritional support treatment), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
Q.2. Which segments will grow at a faster pace and why?
Q.3. Which region will grow at a faster pace and why?
Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
Q.5. What are the business risks and competitive threats in this market?
Q.6. What are the emerging trends in this market and the reasons behind them?
Q.7. What are some of the changing demands of customers in the market?
Q.8. What are the new developments in the market? Which companies are leading these developments?
Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
Q.11. What M&A activity has occurred in the last 8 years and what has its impact been on the industry?

1. Executive Summary

2. Market Overview

2.1 Background and Classifications
2.2 Supply Chain

3. Market Trends & Forecast Analysis

3.1 Macroeconomic Trends and Forecasts
3.2 Industry Drivers and Challenges
3.3 PESTLE Analysis
3.4 Patent Analysis
3.5 Regulatory Environment

4. Global Implantable Venous Access Port Market by Type

4.1 Overview
4.2 Attractiveness Analysis by Type
4.3 Titanium Infusion Port : Trends and Forecast 2019 to 2035
4.4 Plastic Infusion Port : Trends and Forecast 2019 to 2035

5. Global Implantable Venous Access Port Market by Application

5.1 Overview
5.2 Attractiveness Analysis by Application
5.3 Intravenous Chemotherapy : Trends and Forecast 2019 to 2035
5.4 Nutritional Support Treatment : Trends and Forecast 2019 to 2035

6. Regional Analysis

6.1 Overview
6.2 Global Implantable Venous Access Port Market by Region

7. North American Implantable Venous Access Port Market

7.1 Overview
7.2 North American Implantable Venous Access Port Market by Type
7.3 North American Implantable Venous Access Port Market by Application
7.4 The United States Implantable Venous Access Port Market
7.5 Canadian Implantable Venous Access Port Market
7.6 Mexican Implantable Venous Access Port Market

8. European Implantable Venous Access Port Market

8.1 Overview
8.2 European Implantable Venous Access Port Market by Type
8.3 European Implantable Venous Access Port Market by Application
8.4 German Implantable Venous Access Port Market
8.5 French Implantable Venous Access Port Market
8.6 Italian Implantable Venous Access Port Market
8.7 Spanish Implantable Venous Access Port Market
8.8 The United Kingdom Implantable Venous Access Port Market

9. APAC Implantable Venous Access Port Market

9.1 Overview
9.2 APAC Implantable Venous Access Port Market by Type
9.3 APAC Implantable Venous Access Port Market by Application
9.4 Chinese Implantable Venous Access Port Market
9.5 Indian Implantable Venous Access Port Market
9.6 Japanese Implantable Venous Access Port Market
9.7 South Korean Implantable Venous Access Port Market
9.8 Indonesian Implantable Venous Access Port Market

10. ROW Implantable Venous Access Port Market

10.1 Overview
10.2 ROW Implantable Venous Access Port Market by Type
10.3 ROW Implantable Venous Access Port Market by Application
10.4 Middle Eastern Implantable Venous Access Port Market
10.5 South American Implantable Venous Access Port Market
10.6 African Implantable Venous Access Port Market

11. Competitor Analysis

11.1 Product Portfolio Analysis
11.2 Operational Integration
11.3 Porter's Five Forces Analysis
- Competitive Rivalry
- Bargaining Power of Buyers
- Bargaining Power of Suppliers
- Threat of Substitutes
- Threat of New Entrants
11.4 Market Share Analysis

12. Opportunities & Strategic Analysis

12.1 Value Chain Analysis
12.2 Growth Opportunity Analysis
- 12.2.1 Growth Opportunity by Type
- 12.2.2 Growth Opportunity by Application
12.3 Emerging Trends in the Global Implantable Venous Access Port Market
12.4 Strategic Analysis
- 12.4.1 New Product Development
- 12.4.2 Certification and Licensing
- 12.4.3 Mergers, Acquisitions, Agreements, Collaborations, and Joint Ventures

13. Company Profiles of the Leading Players Across the Value Chain

13.1 Competitive Analysis Overview
13.2 BD
- Company Overview
- Implantable Venous Access Port Market Business Overview
- New Product Development
- Merger, Acquisition, and Collaboration
- Certification and Licensing
13.3 AngioDynamics
- Company Overview
- Implantable Venous Access Port Market Business Overview
- New Product Development
- Merger, Acquisition, and Collaboration
- Certification and Licensing
13.4 ICU Medical
- Company Overview
- Implantable Venous Access Port Market Business Overview
- New Product Development
- Merger, Acquisition, and Collaboration
- Certification and Licensing
13.5 B. Braun Medical
- Company Overview
- Implantable Venous Access Port Market Business Overview
- New Product Development
- Merger, Acquisition, and Collaboration
- Certification and Licensing
13.6 PFM Medical
- Company Overview
- Implantable Venous Access Port Market Business Overview
- New Product Development
- Merger, Acquisition, and Collaboration
- Certification and Licensing
13.7 Vygon
- Company Overview
- Implantable Venous Access Port Market Business Overview
- New Product Development
- Merger, Acquisition, and Collaboration
- Certification and Licensing
13.8 Districlass
- Company Overview
- Implantable Venous Access Port Market Business Overview
- New Product Development
- Merger, Acquisition, and Collaboration
- Certification and Licensing
13.9 PakuMed
- Company Overview
- Implantable Venous Access Port Market Business Overview
- New Product Development
- Merger, Acquisition, and Collaboration
- Certification and Licensing
13.10 Linhua Medical
- Company Overview
- Implantable Venous Access Port Market Business Overview
- New Product Development
- Merger, Acquisition, and Collaboration
- Certification and Licensing
13.11 Fresenius
- Company Overview
- Implantable Venous Access Port Market Business Overview
- New Product Development
- Merger, Acquisition, and Collaboration
- Certification and Licensing

14. Appendix

14.1 List of Figures
14.2 List of Tables
14.3 Research Methodology
14.4 Disclaimer
14.5 Copyright
14.6 Abbreviations and Technical Units
14.7 About Us
14.8 Contact Us

簡介目錄圖表

List of Figures

Figure 1.1: Trends and Forecast for the Global Implantable Venous Access Port Market
Figure 2.1: Usage of Implantable Venous Access Port Market
Figure 2.2: Classification of the Global Implantable Venous Access Port Market
Figure 2.3: Supply Chain of the Global Implantable Venous Access Port Market
Figure 3.1: Trends of the Global GDP Growth Rate
Figure 3.2: Trends of the Global Population Growth Rate
Figure 3.3: Trends of the Global Inflation Rate
Figure 3.4: Trends of the Global Unemployment Rate
Figure 3.5: Trends of the Regional GDP Growth Rate
Figure 3.6: Trends of the Regional Population Growth Rate
Figure 3.7: Trends of the Regional Inflation Rate
Figure 3.8: Trends of the Regional Unemployment Rate
Figure 3.9: Trends of Regional Per Capita Income
Figure 3.10: Forecast for the Global GDP Growth Rate
Figure 3.11: Forecast for the Global Population Growth Rate
Figure 3.12: Forecast for the Global Inflation Rate
Figure 3.13: Forecast for the Global Unemployment Rate
Figure 3.14: Forecast for the Regional GDP Growth Rate
Figure 3.15: Forecast for the Regional Population Growth Rate
Figure 3.16: Forecast for the Regional Inflation Rate
Figure 3.17: Forecast for the Regional Unemployment Rate
Figure 3.18: Forecast for Regional Per Capita Income
Figure 3.19: Driver and Challenges of the Implantable Venous Access Port Market
Figure 4.1: Global Implantable Venous Access Port Market by Type in 2019, 2026, and 2035
Figure 4.2: Trends of the Global Implantable Venous Access Port Market ($B) by Type
Figure 4.3: Forecast for the Global Implantable Venous Access Port Market ($B) by Type
Figure 4.4: Trends and Forecast for Titanium Infusion Port in the Global Implantable Venous Access Port Market (2019-2035)
Figure 4.5: Trends and Forecast for Plastic Infusion Port in the Global Implantable Venous Access Port Market (2019-2035)
Figure 5.1: Global Implantable Venous Access Port Market by Application in 2019, 2026, and 2035
Figure 5.2: Trends of the Global Implantable Venous Access Port Market ($B) by Application
Figure 5.3: Forecast for the Global Implantable Venous Access Port Market ($B) by Application
Figure 5.4: Trends and Forecast for Intravenous Chemotherapy in the Global Implantable Venous Access Port Market (2019-2035)
Figure 5.5: Trends and Forecast for Nutritional Support Treatment in the Global Implantable Venous Access Port Market (2019-2035)
Figure 6.1: Trends of the Global Implantable Venous Access Port Market ($B) by Region (2019-2026)
Figure 6.2: Forecast for the Global Implantable Venous Access Port Market ($B) by Region (2027-2035)
Figure 7.1: Trends and Forecast for the North American Implantable Venous Access Port Market (2019-2035)
Figure 7.2: North American Implantable Venous Access Port Market by Type in 2019, 2026, and 2035
Figure 7.3: Trends of the North American Implantable Venous Access Port Market ($B) by Type (2019-2026)
Figure 7.4: Forecast for the North American Implantable Venous Access Port Market ($B) by Type (2027-2035)
Figure 7.5: North American Implantable Venous Access Port Market by Application in 2019, 2026, and 2035
Figure 7.6: Trends of the North American Implantable Venous Access Port Market ($B) by Application (2019-2026)
Figure 7.7: Forecast for the North American Implantable Venous Access Port Market ($B) by Application (2027-2035)
Figure 7.8: Trends and Forecast for the United States Implantable Venous Access Port Market ($B) (2019-2035)
Figure 7.9: Trends and Forecast for the Mexican Implantable Venous Access Port Market ($B) (2019-2035)
Figure 7.10: Trends and Forecast for the Canadian Implantable Venous Access Port Market ($B) (2019-2035)
Figure 8.1: Trends and Forecast for the European Implantable Venous Access Port Market (2019-2035)
Figure 8.2: European Implantable Venous Access Port Market by Type in 2019, 2026, and 2035
Figure 8.3: Trends of the European Implantable Venous Access Port Market ($B) by Type (2019-2026)
Figure 8.4: Forecast for the European Implantable Venous Access Port Market ($B) by Type (2027-2035)
Figure 8.5: European Implantable Venous Access Port Market by Application in 2019, 2026, and 2035
Figure 8.6: Trends of the European Implantable Venous Access Port Market ($B) by Application (2019-2026)
Figure 8.7: Forecast for the European Implantable Venous Access Port Market ($B) by Application (2027-2035)
Figure 8.8: Trends and Forecast for the German Implantable Venous Access Port Market ($B) (2019-2035)
Figure 8.9: Trends and Forecast for the French Implantable Venous Access Port Market ($B) (2019-2035)
Figure 8.10: Trends and Forecast for the Spanish Implantable Venous Access Port Market ($B) (2019-2035)
Figure 8.11: Trends and Forecast for the Italian Implantable Venous Access Port Market ($B) (2019-2035)
Figure 8.12: Trends and Forecast for the United Kingdom Implantable Venous Access Port Market ($B) (2019-2035)
Figure 9.1: Trends and Forecast for the APAC Implantable Venous Access Port Market (2019-2035)
Figure 9.2: APAC Implantable Venous Access Port Market by Type in 2019, 2026, and 2035
Figure 9.3: Trends of the APAC Implantable Venous Access Port Market ($B) by Type (2019-2026)
Figure 9.4: Forecast for the APAC Implantable Venous Access Port Market ($B) by Type (2027-2035)
Figure 9.5: APAC Implantable Venous Access Port Market by Application in 2019, 2026, and 2035
Figure 9.6: Trends of the APAC Implantable Venous Access Port Market ($B) by Application (2019-2026)
Figure 9.7: Forecast for the APAC Implantable Venous Access Port Market ($B) by Application (2027-2035)
Figure 9.8: Trends and Forecast for the Japanese Implantable Venous Access Port Market ($B) (2019-2035)
Figure 9.9: Trends and Forecast for the Indian Implantable Venous Access Port Market ($B) (2019-2035)
Figure 9.10: Trends and Forecast for the Chinese Implantable Venous Access Port Market ($B) (2019-2035)
Figure 9.11: Trends and Forecast for the South Korean Implantable Venous Access Port Market ($B) (2019-2035)
Figure 9.12: Trends and Forecast for the Indonesian Implantable Venous Access Port Market ($B) (2019-2035)
Figure 10.1: Trends and Forecast for the ROW Implantable Venous Access Port Market (2019-2035)
Figure 10.2: ROW Implantable Venous Access Port Market by Type in 2019, 2026, and 2035
Figure 10.3: Trends of the ROW Implantable Venous Access Port Market ($B) by Type (2019-2026)
Figure 10.4: Forecast for the ROW Implantable Venous Access Port Market ($B) by Type (2027-2035)
Figure 10.5: ROW Implantable Venous Access Port Market by Application in 2019, 2026, and 2035
Figure 10.6: Trends of the ROW Implantable Venous Access Port Market ($B) by Application (2019-2026)
Figure 10.7: Forecast for the ROW Implantable Venous Access Port Market ($B) by Application (2027-2035)
Figure 10.8: Trends and Forecast for the Middle Eastern Implantable Venous Access Port Market ($B) (2019-2035)
Figure 10.9: Trends and Forecast for the South American Implantable Venous Access Port Market ($B) (2019-2035)
Figure 10.10: Trends and Forecast for the African Implantable Venous Access Port Market ($B) (2019-2035)
Figure 11.1: Porter's Five Forces Analysis of the Global Implantable Venous Access Port Market
Figure 11.2: Market Share (%) of Top Players in the Global Implantable Venous Access Port Market (2026)
Figure 12.1: Growth Opportunities for the Global Implantable Venous Access Port Market by Type
Figure 12.2: Growth Opportunities for the Global Implantable Venous Access Port Market by Application
Figure 12.3: Growth Opportunities for the Global Implantable Venous Access Port Market by Region
Figure 12.4: Emerging Trends in the Global Implantable Venous Access Port Market

List of Tables

Table 1.1: Growth Rate (%, 2025-2026) and CAGR (%, 2027-2035) of the Implantable Venous Access Port Market by Type and Application
Table 1.2: Attractiveness Analysis for the Implantable Venous Access Port Market by Region
Table 1.3: Global Implantable Venous Access Port Market Parameters and Attributes
Table 3.1: Trends of the Global Implantable Venous Access Port Market (2019-2026)
Table 3.2: Forecast for the Global Implantable Venous Access Port Market (2027-2035)
Table 4.1: Attractiveness Analysis for the Global Implantable Venous Access Port Market by Type
Table 4.2: Market Size and CAGR of Various Type in the Global Implantable Venous Access Port Market (2019-2026)
Table 4.3: Market Size and CAGR of Various Type in the Global Implantable Venous Access Port Market (2027-2035)
Table 4.4: Trends of Titanium Infusion Port in the Global Implantable Venous Access Port Market (2019-2026)
Table 4.5: Forecast for Titanium Infusion Port in the Global Implantable Venous Access Port Market (2027-2035)
Table 4.6: Trends of Plastic Infusion Port in the Global Implantable Venous Access Port Market (2019-2026)
Table 4.7: Forecast for Plastic Infusion Port in the Global Implantable Venous Access Port Market (2027-2035)
Table 5.1: Attractiveness Analysis for the Global Implantable Venous Access Port Market by Application
Table 5.2: Market Size and CAGR of Various Application in the Global Implantable Venous Access Port Market (2019-2026)
Table 5.3: Market Size and CAGR of Various Application in the Global Implantable Venous Access Port Market (2027-2035)
Table 5.4: Trends of Intravenous Chemotherapy in the Global Implantable Venous Access Port Market (2019-2026)
Table 5.5: Forecast for Intravenous Chemotherapy in the Global Implantable Venous Access Port Market (2027-2035)
Table 5.6: Trends of Nutritional Support Treatment in the Global Implantable Venous Access Port Market (2019-2026)
Table 5.7: Forecast for Nutritional Support Treatment in the Global Implantable Venous Access Port Market (2027-2035)
Table 6.1: Market Size and CAGR of Various Regions in the Global Implantable Venous Access Port Market (2019-2026)
Table 6.2: Market Size and CAGR of Various Regions in the Global Implantable Venous Access Port Market (2027-2035)
Table 7.1: Trends of the North American Implantable Venous Access Port Market (2019-2026)
Table 7.2: Forecast for the North American Implantable Venous Access Port Market (2027-2035)
Table 7.3: Market Size and CAGR of Various Type in the North American Implantable Venous Access Port Market (2019-2026)
Table 7.4: Market Size and CAGR of Various Type in the North American Implantable Venous Access Port Market (2027-2035)
Table 7.5: Market Size and CAGR of Various Application in the North American Implantable Venous Access Port Market (2019-2026)
Table 7.6: Market Size and CAGR of Various Application in the North American Implantable Venous Access Port Market (2027-2035)
Table 7.7: Trends and Forecast for the United States Implantable Venous Access Port Market (2019-2035)
Table 7.8: Trends and Forecast for the Mexican Implantable Venous Access Port Market (2019-2035)
Table 7.9: Trends and Forecast for the Canadian Implantable Venous Access Port Market (2019-2035)
Table 8.1: Trends of the European Implantable Venous Access Port Market (2019-2026)
Table 8.2: Forecast for the European Implantable Venous Access Port Market (2027-2035)
Table 8.3: Market Size and CAGR of Various Type in the European Implantable Venous Access Port Market (2019-2026)
Table 8.4: Market Size and CAGR of Various Type in the European Implantable Venous Access Port Market (2027-2035)
Table 8.5: Market Size and CAGR of Various Application in the European Implantable Venous Access Port Market (2019-2026)
Table 8.6: Market Size and CAGR of Various Application in the European Implantable Venous Access Port Market (2027-2035)
Table 8.7: Trends and Forecast for the German Implantable Venous Access Port Market (2019-2035)
Table 8.8: Trends and Forecast for the French Implantable Venous Access Port Market (2019-2035)
Table 8.9: Trends and Forecast for the Spanish Implantable Venous Access Port Market (2019-2035)
Table 8.10: Trends and Forecast for the Italian Implantable Venous Access Port Market (2019-2035)
Table 8.11: Trends and Forecast for the United Kingdom Implantable Venous Access Port Market (2019-2035)
Table 9.1: Trends of the APAC Implantable Venous Access Port Market (2019-2026)
Table 9.2: Forecast for the APAC Implantable Venous Access Port Market (2027-2035)
Table 9.3: Market Size and CAGR of Various Type in the APAC Implantable Venous Access Port Market (2019-2026)
Table 9.4: Market Size and CAGR of Various Type in the APAC Implantable Venous Access Port Market (2027-2035)
Table 9.5: Market Size and CAGR of Various Application in the APAC Implantable Venous Access Port Market (2019-2026)
Table 9.6: Market Size and CAGR of Various Application in the APAC Implantable Venous Access Port Market (2027-2035)
Table 9.7: Trends and Forecast for the Japanese Implantable Venous Access Port Market (2019-2035)
Table 9.8: Trends and Forecast for the Indian Implantable Venous Access Port Market (2019-2035)
Table 9.9: Trends and Forecast for the Chinese Implantable Venous Access Port Market (2019-2035)
Table 9.10: Trends and Forecast for the South Korean Implantable Venous Access Port Market (2019-2035)
Table 9.11: Trends and Forecast for the Indonesian Implantable Venous Access Port Market (2019-2035)
Table 10.1: Trends of the ROW Implantable Venous Access Port Market (2019-2026)
Table 10.2: Forecast for the ROW Implantable Venous Access Port Market (2027-2035)
Table 10.3: Market Size and CAGR of Various Type in the ROW Implantable Venous Access Port Market (2019-2026)
Table 10.4: Market Size and CAGR of Various Type in the ROW Implantable Venous Access Port Market (2027-2035)
Table 10.5: Market Size and CAGR of Various Application in the ROW Implantable Venous Access Port Market (2019-2026)
Table 10.6: Market Size and CAGR of Various Application in the ROW Implantable Venous Access Port Market (2027-2035)
Table 10.7: Trends and Forecast for the Middle Eastern Implantable Venous Access Port Market (2019-2035)
Table 10.8: Trends and Forecast for the South American Implantable Venous Access Port Market (2019-2035)
Table 10.9: Trends and Forecast for the African Implantable Venous Access Port Market (2019-2035)
Table 11.1: Product Mapping of Implantable Venous Access Port Suppliers Based on Segments
Table 11.2: Operational Integration of Implantable Venous Access Port Manufacturers
Table 11.3: Rankings of Suppliers Based on Implantable Venous Access Port Revenue
Table 12.1: New Product Launches by Major Implantable Venous Access Port Producers (2019-2026)
Table 12.2: Certification Acquired by Major Competitor in the Global Implantable Venous Access Port Market